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cessful in 95% of those attempted. An aggressive follow-up
protocol can double the retrieval rates previously reported
while the risk of fracture/embolization is1%when filters are
aggressively removed at a mean of 246 days.
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Objectives: Retrievable inferior vena cava (IVC) filters
were introduced to provide protection from pulmonary
emboli (PE) in patients with short-term PE risk, with the
option to be removed once the PE risk subsides. However,
many filters are not removed and there are increasing
reports describing complications from retrievable filters
including IVC perforation, erosion into adjacent struc-
tures, migration, and filter fracture. Importantly, the fre-
quency of these complications is likely to increase as
greater numbers of IVC filters are being placed and we
describe our experience with open filter explantation for
IVC perforation.
Methods: We describe 5 cases of open filter explanta-
tion for IVC perforation by retrievable IVC filters following
unsuccessful endovascular retrieval.
Results: Five patients underwent successful laparot-
omy and explantation of retrievable IVC filters. Three
filters were placed for PE prophylaxis in high-risk patients
prior to elective surgical intervention. Two others were
placed in patients with PE and contraindications to antico-
agulation. All patients had radiographic evidence of cava
penetration by the filter. 4 patients had symptoms attrib-
uted to erosion into adjacent bowel, including one patient
with endoscopic evidence of duodenal penetration. One
patient was asymptomatic but had radiographic evidence of
aortic penetration by a filter leg. All patients had improve-
ment in symptoms and uncomplicated recoveries following
explantation.
Conclusions: This is the largest case series to date
describing the open explantation of IVC filters for IVC
perforation and erosion into adjacent structures. We advo-
cate early endovascular retrieval of IVC filters as soon as PE
risk subsides to avoid long-term complications of retriev-
able IVC filters. In cases of IVC perforation open removal
of IVC filters can be performed safely with minimal risk
when endovascular retrieval is unsuccessful.
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Objectives: Statin therapy has been shown to reduce
adverse cardiovascular events in patients with peripheral
artery disease, but their effect on outcomes after lower
extremity endovascular interventions remains uncertain.
The aim of this study was to determine if statin therapy
improves clinical outcomes after endovascular intervention
in patients with critical limb ischemia (CLI).
Methods: A retrospective review of all patients under-
going endovascular treatment for CLI was performed. Pa-
tients were grouped based on whether or not they were
receiving statin therapy at the time of intitial intervention
for CLI. Demographics, lesion type and TASC classifica-
tion as well as overall mortality, primary and secondary
patency and limb salvage were then compared between
these groups. Analysis was performed using multivariate
regression and Kaplan-Meier analysis.
Results: 646 patients (904 limbs) underwent endovas-
cular intervention for CLI between 2004 and 2009. The
statin group had significantly higher rates of diabetes
mellitus, coronary artery disease, congestive heart fail-
ure, previous myocardial infarction and coronary artery
bypass procedure (P0.05). The two groups had similar
lesion characteristics, TASC classification and primary
procedure. At 24 months, the statin-treated group had
higher rates of primary patency (43% vs. 33%; P.007),
secondary patency (66% vs. 51%; P.001), limb salvage
(83% vs. 62%; P.001) and overall survival (77% vs. 62%;
P.038). Statin therapy was also independently associ-
ated with improved limb salvage by multivariate regres-
sion analysis (HR0.315; P.001).
Conclusions: Patients receiving statin therapy at the
time of initial intervention for treatment of CLI had signif-
icantly improved overall survival, primary and secondary
patency and limb salvage rates. Our findings suggest that
statins should be part of the periprocedural treatment reg-
imen for patients undergoing endovascular treatment of
CLI and supports further investigation into the beneficial
effects of statins in CLI.
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